HealthcarePress Releases

Microfluidics Market Size to Hit $62 billion in 2030

Share This Article
[150+ Pages Report] The microfluidics market revenue share is set to grow at a yearly rate of 16.5% during 2021-2030, while its valuation is Projected to jump from $18 billion in 2021 to $62 billion in 2030.

The microfluidics market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2030.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1116

This research report evaluates the microfluidics market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global microfluidics market for the period from 2017 to 2030.

Growth Factors

Rising demand for Point of Care (POC) testing in a wide range of applications because of the benefits associated with the incorporation of microfluidics along with high return on investments anticipated to propel the market growth of microfluidics during the analysis period. In addition, high-throughput screening methodologies, low-volume sample analysis, and increased demand for in vitro diagnostics (IVD) expected to offer numerous growth opportunities for the players operating in the microfluidics market during the forthcoming years. On the contrary, lack of market visibility for the microfluidics products coupled with high prices of the microfluidics sensors and integrated systems is the key factor that restrict the market growth.

Microfluidics has been successfully applied for the manufacturing of a diverse range of commercial products. For example, integrated fluidic circuits designed by the Fluidigm Corporation offers sample throughput that is comparatively high and provides cost-effective solutions for multiplex single-nucleotide polymorphism genotyping. Likewise, another manufacturer named Quanta Life that provides droplet-based microfluidic solutions for carrying out digital PCR for quantification of nucleic acids.

Caliper Life Sciences offers LabChip systems that use a glass microfluidic chip to receive a high-throughput fluorescent and electrophoretic analysis of protein fragments and nucleic acid. Further, technological advancement is the key factor that drives the market growth. For instance, organ-on-chips are the microfluidic devices that are used for culturing living cells in constantly perfused and micrometer-sized chambers to model physiological functions of tissues and organs.

Market Report Scope

Report Highlights Details
Market Size USD 62 billion by 2030
Growth Rate CAGR of 16.5% from 2021 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2027

For More Information or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1116

This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global microfluidics market for the forecast period of 2021–2030. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global microfluidics market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

Key Highlights

  • North America emerged as the largest share holder in the global microfluidics market owing to the presence of well-established market players in the region
  • The Asia Pacific encountered to be the fastest growing market because of affordable labor, sophisticated research infrastructure, and adoption of microfluidic platforms
  • The PDMS-based microfluidic chips segment led the global microfluidics market in terms of revenue in 2019 and expected to register the fastest growth rate over the analysis period
  • Polymer-based microfluidic devices proved as a better alternative to the glass and silicon-based microfluidic devices
  • Based on technology, the medical technology segment dominated the global market in 2019 owing to the major benefits offered by the microfluidics for the POC diagnostics
  • The lab-on-a-chip application accounted for the largest value share in the global market and estimated to continue its dominance throughout the analysis period
  • North America holds the largest value share in the global market for microfluidics. The growth of the region is mainly attributed to better reimbursement policies, well-established healthcare system, and the higher adoption of novel therapeutics among the common population.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1116

Competition Landscape

In the final section of the research report, Precedence Research provided the global microfluidics market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.

Some of the major players in the microfluidics market include:

  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Life Technologies Corporation
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Fluidigm Corporation
  • Qiagen N.V.
  • Thermo Fischer Scientific
  • Biomérieux
  • Cellix Ltd.
  • Elveflow
  • Micronit Micro Technologies B.V.

Market Segmentation

By Material

  • Glass
  • Silicon
  • PDMS
  • Polymers
  • Others

By Technology

  • Non-Medical
  • Medical
    • Gel Electrophoresis
    • PCR & RT-PCR
    • ELISA
    • Microarrays
    • Others

By Application

  • Organs-on-chips
  • Lab-on-a-chip
  • Continuous Flow Microfluidics
  • Acoustofluidics and Microfluidics
  • Optofluidics and Microfluidics
  • Electrophoresis and Microfluidics

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

  • Market estimate for 2020
  • Average selling price (ASP) per region for specific product type
  • Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
  • Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
  • National government documents, statistical databases
  • News articles, press releases, and webcasts specific to companies operating in the market
  • Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
  • Determination of market penetration by country

Most Asked Questions –

What was the market size value of the microfluidics in 2020?

What is the expected market size by 2030?

What is the microfluidics market growth?

What are the key factors that positively influence market growth?

Who are the prominent players in the microfluidics market?

Why Buy this Report?

The purpose of Precedence Research’s microfluidics market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Microfluidics Market, By Material

7.1. Microfluidics Market, by Material Type, 2021-2030
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Microfluidics Market, By Application

8.1. Microfluidics Market, by Application, 2021-2030
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Microfluidics Market, By Technology

9.1. Microfluidics Market, by Technology, 2021-2030
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Microfluidics Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. Market Revenue and Forecast, by Technology (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.7.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4.3. Market Revenue and Forecast, by Technology (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.5.3. Market Revenue and Forecast, by Technology (2017-2030)

Chapter 11. Company Profiles

11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1116

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: mailto:sales@precedenceresearch.com

For Latest Update Follow Us:

https://www.linkedin.com/company/precedence-research/

https://www.facebook.com/precedenceresearch/

https://twitter.com/Precedence_R

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button